Summary of opinion: Veyvondi,vonicog alfa, 12/10/2023, Positive
On 12 October 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Veyvondi. The marketing authorisation holder for this …